☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Senhwa Biosciences
Senhwa Bioscience’s Silmitasertib Received the US FDA IND Approval to treat patients with community-acquired pneumonia (CAP)
November 22, 2023
Insights+: COVID-19 Healthcare News Monthly Updates - November 2020
November 26, 2020
Load more...
Back to Home
